Calendar · pharmadog

Sign In Subscribe

Week of Feb 16, 2026

50

Feb 17, 2026approval178d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

full page →ALDACTAZIDE →fda approvals ↗

Feb 17, 2026approval178d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

full page →ALDACTAZIDE →fda approvals ↗

Feb 17, 2026approval178d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

full page →ALDACTAZIDE →fda approvals ↗

Feb 17, 2026approval178d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

full page →ALDACTAZIDE →fda approvals ↗

Feb 17, 2026approval178d agoSODIUM PHENYLBUTYRATE — FDA approvalSODIUM PHENYLBUTYRATE

Sponsor: NAVINTA LLC. Form: TABLET. Route: ORAL

full page →SODIUM PHENYLBUTYRATE →fda approvals ↗

Feb 17, 2026approval178d agoDEXMEDETOMIDINE HYDROCHLORIDE — FDA approvalDEXMEDETOMIDINE HYDROCHLORIDE

Sponsor: TAGI. Form: INJECTABLE. Route: INJECTION

full page →DEXMEDETOMIDINE HYDROCHLORIDE →fda approvals ↗

Feb 17, 2026approval178d agoCOLCHICINE — FDA approvalCOLCHICINE

Sponsor: MICRO LABS. Form: CAPSULE. Route: ORAL

full page →COLCHICINE →fda approvals ↗

Feb 17, 2026approval178d agoAMBRISENTAN — FDA approvalAMBRISENTAN

Sponsor: SIGMAPHARM LABS LLC. Form: TABLET. Route: ORAL

full page →AMBRISENTAN →fda approvals ↗

Feb 17, 2026approval178d agoMEDICAL AIR, USP — FDA approval

Sponsor: INDUSTRIAL WELDING SUPPLY CO OF HARVEY INC. Form: GAS. Route: INHALATION

full page →fda approvals ↗

Feb 17, 2026approval178d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

Feb 17, 2026approval178d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

Feb 17, 2026approval178d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

Feb 17, 2026approval178d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

Feb 17, 2026approval178d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

Feb 17, 2026approval178d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

Feb 17, 2026approval178d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

Feb 17, 2026approval178d agoLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

full page →ALDACTAZIDE →fda approvals ↗

Feb 17, 2026approval178d agoNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (ETHINYL ESTRADIOL) — FDA approvalNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

Sponsor: APOTEX. Form: TABLET. Route: ORAL

full page →NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE →fda approvals ↗

Feb 17, 2026approval178d agoMETRONIDAZOLE — FDA approvalMETRONIDAZOLE

Sponsor: ALEMBIC. Form: GEL. Route: TOPICAL

full page →METRONIDAZOLE →fda approvals ↗

Feb 17, 2026approval178d agoMETRONIDAZOLE — FDA approvalMETRONIDAZOLE

Sponsor: ALEMBIC. Form: GEL. Route: TOPICAL

full page →METRONIDAZOLE →fda approvals ↗

Feb 17, 2026approval178d agoRELGAABI (GABAPENTIN) — FDA approvalSciegen Pharmaceuticals Inc

Sponsor: SCIEGEN PHARMS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 17, 2026approval178d agoANAGRELIDE HYDROCHLORIDE — FDA approvalTakeda Pharmaceuticals USA Inc

Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 17, 2026approval178d agoAMLODIPINE BESYLATE — FDA approvalGraviti Pharmaceuticals Inc

Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 17, 2026approval178d agoMEROPENEM — FDA approvalMEROPENEM

Sponsor: QILU. Form: INJECTABLE. Route: INJECTION

full page →MEROPENEM →fda approvals ↗

Feb 17, 2026device 510k178d agoBiomendex OY — Adaptos®Fuse Bone Graft (510k cleared)

Product code: MQV. Advisory committee: Orthopedic. Type: Traditional

full page →fda device 510k ↗

Feb 17, 2026device 510k178d agoLiquet Medical, Inc. — Versus Catheter (VS110-9NB) (510k cleared)

Product code: QEY. Advisory committee: Cardiovascular. Type: Special

full page →fda device 510k ↗

Feb 17, 2026device 510k178d agoJiangsu Yuyue Medical Equipment & Supply Co., Ltd. — YUWELL® Finger Pulse Oximeter (YX105, YX106, YX110, YX310) (510k cleared)

Product code: DQA. Advisory committee: Cardiovascular. Type: Traditional

full page →fda device 510k ↗

Feb 17, 2026device 510k178d agoBiocomposites, Ltd. — Biosteon® Screw (510k cleared)

Product code: MAI. Advisory committee: Orthopedic. Type: Traditional

full page →fda device 510k ↗

Feb 17, 2026device 510k178d agoFujifilm Corporation — FUJIFILM Endoscope Model EG-S100XT and VS-1000 Display Unit (510k cleared)Fujifilm Holdings Corp

Product code: FDS. Advisory committee: Gastroenterology, Urology. Type: Traditional

full page →fda device 510k ↗

Feb 17, 2026device 510k178d agoNingbo Shenyu Medical Equipment Co.,Ltd — Electric Wheelchair (W-A807, W-A807L) (510k cleared)

Product code: ITI. Advisory committee: Physical Medicine. Type: Traditional

full page →fda device 510k ↗

Feb 17, 2026device 510k178d agoCenterline Biomedical, Inc. — IOPS Visionary System (MC-3); IOPS Viewpoint Simple Curve Catheter, 75cm (C00751); IOPS Viewpoint Simple Curve Catheter, 125cm (C01251); IOPS Viewpoint Double Curve Catheter, 75cm (C00752); IOPS Viewpoint Double Curve Catheter, 125cm (C02152); IOPS Guidewire 2 (ATW-2); IOPS Fiducial Tracking Pad (T02111); IOPS Guidewire Handle (H01035) (510k cleared)

Product code: DQK. Advisory committee: Cardiovascular. Type: Traditional

full page →fda device 510k ↗

Feb 17, 2026device pma178d agoMedtronic, Inc. — PulseSelect Pulsed Field Ablation (PFA) system (PMA supplement)Medtronic plc

Supplement type: Normal 180 Day Track. Product code: QZI. Advisory committee: CV. Decision: APPR

full page →fda device pma ↗

Feb 17, 2026device pma178d agoAlcon Research, LLC — UNIPURE C3F8 Ophthalmic Gas in the UNIFEYE Gas Delivery System, UNIPURE C3F8 Ophthalmic Gas in the UNIPEXY Gas Delivery (PMA supplement)

Supplement type: 30-Day Notice. Product code: LPO. Advisory committee: OP. Decision: OK30

full page →fda device pma ↗

Feb 17, 2026device pma178d agoEndotronix, Inc. — Cordella Pulmonary Artery Sensor System (CorPASS) (PMA supplement)

Supplement type: 30-Day Notice. Product code: MOM. Advisory committee: CV. Decision: OK30

full page →fda device pma ↗

Feb 17, 2026device pma178d agoCooperVision, Inc. — MiSight 1 Day (omafilcon A) Soft (Hydrophilic) Contact Lenses for Daily Wear (PMA supplement)

Supplement type: 30-Day Notice. Product code: QIT. Advisory committee: OP. Decision: OK30

full page →fda device pma ↗

Feb 17, 2026device pma178d agoAlcon Research, LLC — UNIPURE SF6 Ophthalmic Gas in the UNIFEYE Gas Delivery System, UNIPURE SF6 Ophthalmic Gas in the UNIPEXY Gas Delivery Sy (PMA supplement)

Supplement type: 30-Day Notice. Product code: LPO. Advisory committee: OP. Decision: OK30

full page →fda device pma ↗

Feb 17, 2026device recall178d agoMolded Products Inc device recall (Cls II)

See Luer Cap Set, MPC-130, set, administration, intravascular — Reason: Molded Products, Inc. is voluntarily conducting a medical device recall of the MPC-130 See Luer Cap Set based on a confirmed complaint of the threaded sleeve not being engaged and becoming un-attached. — Status: Ongoing

full page →fda device recalls ↗

Feb 17, 2026grant178d agoCHILDREN'S HOSP OF PHILADELPHIA — Role of the PilC1 and PilC2 pilus-associated proteins in Kingella kingae path...PATH

AI grant. $853,112. PI: Joseph W. St. Geme

full page →nih reporter ↗

Feb 17, 2026grant178d agoWASHINGTON STATE UNIVERSITY — Role of Fn-14 receptor in TNF-induced inflammation and tissue destruction

AI grant. $497,779. PI: Salah-uddin Ahmed

full page →nih reporter ↗

Feb 17, 2026grant178d agoUNIVERSITY OF TEXAS DALLAS — Disruption of a DNA Repair Protein Promotes Antibiotic Resistance in Acinetob...

AI grant. $434,625. PI: Nicholas A Dillon

full page →nih reporter ↗

Feb 17, 2026grant178d agoUNIVERSITY OF PENNSYLVANIA — The 22nd International Vasculitis WorkshopUniversity of Pennsylvania

TR grant. $18,000. PI: Peter A Merkel

full page →nih reporter ↗

Feb 17, 2026grant178d agoUNIVERSITY OF CALIFORNIA-IRVINE — Vancomycin-Teixobactin Conjugates

AI grant. $404,866. PI: JAMES S NOWICK

full page →nih reporter ↗

Feb 17, 2026grant178d agoDUKE UNIVERSITY — Identifying Endocrine-Disrupting Plastic Additives using Machine LearningDuke University

ES grant. $444,125. PI: Daniel Reker

full page →nih reporter ↗

Feb 17, 2026grant178d agoJOHNS HOPKINS UNIVERSITY — Modification of the predisposition for ectopic calcificationJohns Hopkins University

OD grant. $388,750. PI: Shira G Ziegler

full page →nih reporter ↗

Feb 17, 2026grant178d agoDUKE UNIVERSITY — Understanding environmental mitochondrial healthDuke University

ES grant. $1,006,211. PI: Joel Newman Meyer

full page →nih reporter ↗

Feb 17, 2026grant178d agoJOHNS HOPKINS UNIVERSITY — Generating Critical Knowledge on the NMP Peptide Signaling in the Peripheral ...Johns Hopkins University

NS grant. $232,938. PI: SETH S MARGOLIS

full page →nih reporter ↗

Feb 18, 2026approval177d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Feb 18, 2026approval177d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Feb 18, 2026approval177d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Feb 18, 2026approval177d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

page 24 of 189